comparemela.com

Latest Breaking News On - Tianqing - Page 5 : comparemela.com

Tencent-Backed AI Drug Discovery Startup Xtalpi Files For Hong Kong IPO

Xtalpi’s last private fundraising was a $380 million Series D round in October 2021 that valued the company at about $2 billion.

Ma-jian
Zhejiang
China
Shenzhen
Guangdong
United-states
Tianqing
Hong-kong
American
Chinese
Wen-shuhao
Neil-shen-hongshan

Inventiva reports 2023 Third Quarter Financial Information¹

Inventiva reports 2023 Third Quarter Financial Information¹
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Russia
Daix
Bourgogne
France
New-york
United-states
South-korea
Israel
Tianqing
Zhejiang
China
San-francisco

Inventiva reports 2023 Third Quarter Financial Information¹

Cash and cash equivalents at €43.8 million, short-term deposits at €0.03 million2, and long-term deposit at €5.0 million3 as of September 30, 2023.

China
France
South-korea
Russia
United-states
San-francisco
California
New-york
Tianqing
Zhejiang
Ukraine
Daix

INVENTIVA: Inventiva reports 2023 Third Quarter Financial Information

INVENTIVA: Inventiva reports 2023 Third Quarter Financial Information
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Daix
Bourgogne
France
China
Israel
South-korea
Tianqing
Zhejiang
Japan
San-francisco
California
United-states

China Bispecific Antibodies Pipeline Market Analysis Report 2023-2028: Emerging Bispecific Antibodies Market has Attracted Numerous Investors, Leading to the Emergence of Startups

/PRNewswire/ The "China Bispecific Antibodies Market and Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com s offering..

China
Dublin
Ireland
Tianqing
Zhejiang
Xuanzhu
Qilu
Gansu
Sanyou
Anhui
Chinese
Linton-pharm

vimarsana © 2020. All Rights Reserved.